Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Flintlock Capital Asset Management taps Butterfield Fulcrum as Exclusive Administrator

Thursday, November 12, 2009
Opalesque Industry Updates - Butterfield Fulcrum, a top five independent alternative fund administration company by assets under administration today announced that it has been selected as the exclusive third-party administrator for Flintlock Capital Asset Management, a discretionary global commodities manager set to launch in early 2010.

“We look to differentiate our fund by being liquid, transparent and understandable,” said David Walker, COO of Flintlock Capital Asset Management. “Butterfield Fulcrum’s real-time reporting of daily operations is integral to our value proposition.”

Flintlock Capital Asset Management selected Butterfield Fulcrum to provide month-end reporting services following a comprehensive administrator search.

“Flintlock Capital Asset Management is indicative of a new generation of hedge funds looking to stay ahead of regulatory and investor requirements by offering extreme reporting capabilities” said Akshaya Bhargava, Butterfield Fulcrum's CEO. “We are pleased to have exceeded their requirements and look forward to a long relationship.” Corporate website: Source

- FG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its